Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger
CINCINNATI, Dec. 12, 2022 /PRNewswire/ — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has entered into a side letter with the buyer, setting the closing date of Meridian’s pending merger for January 31, 2023. As previously disclosed, on July 7, 2022, […]